Takeda Pharmaceutical Company Limited
4502
Rank in Stocks
#378
Takeda Pharmaceutical Company Limited is a global biopharmaceutical enterprise... Takeda Pharmaceutical Company Limited is a global biopharmaceutical enterprise engaged in the discovery, development, manufacturing, marketing, and out-licensing of various medical products. The company's operations span Japan, the United States, Europe, Canada, Latin America, Russia, and other regions across Asia and internationally. Takeda concentrates its efforts on key therapeutic areas such as gastroenterology, rare diseases, plasma-derived therapies, oncology, and neuroscience. Its extensive product range includes well-known brands like Entyvio, Takhzyro, Velcade, and Vyvanse. To advance its pipeline and innovation, Takeda actively fosters numerous collaborations, in-licensing agreements, research partnerships, and strategic alliances with a diverse array of organizations, including academic institutions like the University of Texas MD Anderson Cancer Center and biotech firms such as Neurocrine Biosciences, Inc. and Arrowhead Pharmaceuticals Inc. Established in 1781, the company maintains its headquarters in Tokyo, Japan.
Share Price
$40.26
Market Cap
$64.06B
Change (1 day)
0.71%
Change (1 year)
42.44%
Country
JP
Trade Takeda Pharmaceutical Company Limited (4502)
Category
Healthcare
Stock split history for Takeda Pharmaceutical Company Limited (4502)
Takeda Pharmaceutical Company Limited stock (symbol: 4502) underwent a total of 0 stock splits.
The most recent stock split occurred on Oct 22, 2026.
One 4502 share bought prior to Oct 22, 2026 would equal to 0 4502 shares today.
The most recent stock split occurred on Oct 22, 2026.
One 4502 share bought prior to Oct 22, 2026 would equal to 0 4502 shares today.
Stock split list
| Year | Split | Multiple | Cumulative Multiple |
|---|---|---|---|
| Not enough data for the provided dates. | |||
Stock splits for similar companies or competitors
| Company | Number of stock splits | Cumulative Multiple | Country |
|---|---|---|---|
| 0 | - |
DE
|
|
| 0 | - |
DE
|
|
| 0 | - |
CH
|
|
| 5 | x119 |
IN
|
|
| 0 | - |
CN
|
